|
Drug Information
Pharmacokinetics
| Indication
& Dosage | Action
| Interactions |Adverse
Effects & Precautions |
Brands available in Market
Indication
& Dosage
IM/IV
UNDER FULL OBSTETRIC SUPERVISION TO SHORTEN THIRD STAGE OF LABOR
FOLLOWING DELIVER OF ANTERIOR SHOULDER; ROUTINE MANAGEMENT AFTER
DELIVERY OF PLACENTA; POSTPARTUM OR POSTABORTAL ATONY & HEMORRHAGE:
0.2mg IM; may be repeated as reqd, at intervals of 2-4 hrs. IV use is
not routinely advocated unless as an emergency measure. IV DOSE SAME AS
IM DOSE.
ORAL
MILD POSTPARTUM HEMORRHAGE; UTERINE SUBINVOLUTION: 0.2mg t.i.d/q.i.d. in
the pureperuim for a maximum of one week.
Action
Selective stimulant on uterine muscle especially towards term, during
labour and postpartum. Sensitivity of the uterus to oxytocin increases
throughout the pregnancy reaching the maximum at term.
Interaction
Sympathomimetics: Pressor
effect of sympathomimetics may be increased leading to postpartum
hypertension.
Prostaglandins: Risk of uterine rupture and cerival lacerations.
Ergotamine: Synergistic effect in control of post partum hemorrhage.
Adverse Effect &
Precautions
Inj: Tachycardia, hypotension,
ECG changes water intoxication.
Precaution: I.V. Infusion to be given under close medical supervision
and careful monitoring of the patient is to be done, cardiovascular
disorders, hypersensitivity.